Enhancing National Covid-19 Screening and Diagnostic Support Capacity in Uganda

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:14 publications

Grant number: MC_PC_20001

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $49,080
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Pending
  • Research Location

    Uganda
  • Lead Research Institution

    London School of Hygiene & Tropical Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    13

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This £40k award award is to procure an Applied Biosystems Real Time PCR machine to support the Centres important work on COVID-19. This exceptional award is being made in recognition of the fact that research will be critical in overcoming this epidemic.

Publicationslinked via Europe PMC

An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2.

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.

SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.

HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting.

Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda.

Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021.

SARS-CoV-2 Variants, South Sudan, January-March 2021.